Quest Diagnostics (DGX) said Wednesday that it now expects that worse-than-expected weather to trim Q1 revenue by $25 million and EPS by $0.10.
The medical testing services company also said it continues to expect 2025 adjusted diluted earnings of $9.55 to $9.80 per share on net revenue of $10.70 billion to $10.85 billion.
Analysts polled by FactSet expect non-GAAP EPS of $9.71 on sales of $10.79 billion.
Shares of the company were down more than 1% in recent premarket activity on Wednesday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。